Evidence map›Paper›PMID 28763248›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2017

Evaluating Commercially Available Antibodies for Rat α7 Nicotinic Acetylcholine Receptors.

Brijesh K Garg, Ralph H Loring

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. January in focus in HCB: antibody validation.Histochemistry and cell biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Therapeutic Targeting ofPharmacological reviews · 2021
    Review
  10. Article
  11. Article
  12. Nicotinic Receptor Subunits Atlas in the Adult Human Lung.International journal of molecular sciences · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Ten Basic Rules of Antibody Validation.Analytical chemistry insights · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Brijesh K GargDepartment of Pharmaceutical Science, Northeastern University, Boston, Massachusetts (BKG, RHL).
Ralph H LoringDepartment of Pharmaceutical Science, Northeastern University, Boston, Massachusetts (BKG, RHL).
Northeastern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha7 nicotinic acetylcholine receptors (α7 nAChRs) are important drug targets in neurological disorders and inflammation, making their detection and localization by validated antibodies highly desirable. However, tests in knockout animals raised questions about specificity of antibodies to mouse α7 nAChRs. To date, methods for validating antibodies for rat or human α7 nAChR have not been reported. We developed a gel-shift assay for western blots using GH4C1 cells expressing either native rat receptors or α7 nAChR-green fluorescent protein (GFP) chimeras to evaluate seven commercially available α7 nAChR antibodies. Blots with anti-GFP antibody detected GFP or α7 nAChR-GFP expressed in GH4C1 cells, and

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorAnimalsAntibodiesBlotting, WesternCells, CulturedFluorescent Antibody TechniqueRatsReproducibility of Resultsalpha7 Nicotinic Acetylcholine ReceptorAntibodiesantibody validationChrna7MAb 306MAb 319monoclonalNBP1-79948protein detection

Identifiers

PMID28763248
PMCPMC5582671
OpenAlexW2740367159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.